Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
about
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.FAK and paxillin, two potential targets in pancreatic cancerMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerInhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.Genetic and epigenetic silencing of SCARA5 may contribute to human hepatocellular carcinoma by activating FAK signaling.Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.uPAR/cathepsin B overexpression reverse angiogenesis by rescuing FAK phosphorylation in uPAR/cathepsin B down regulated meningioma.Antineoplastic effects of gamma linolenic Acid on hepatocellular carcinoma cell lines.Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinomaPhosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.Focal adhesion kinase (FAK) mediates the induction of pro-oncogenic and fibrogenic phenotypes in hepatitis C virus (HCV)-infected cells.FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis.Protein tyrosine phosphatases PTP-1B, SHP-2, and PTEN facilitate Rb/E2F-associated apoptotic signaling.Prognostic Value of Focal Adhesion Kinase (FAK) in Human Solid Carcinomas: A Meta-Analysis.Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular CarcinomaFocal adhesion kinase overexpression and its impact on human osteosarcoma.The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cellsExpression of focal adhesion kinase in small-cell lung carcinoma.Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.Soft matrices downregulate FAK activity to promote growth of tumor-repopulating cells.Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence.Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.FAK Kinase Activity Is Required for the Progression of c-MET/β-Catenin-Driven Hepataocellular Carcinoma.Hepatocellular tumors: immunohistochemical analyses for classification and prognostication.Focal adhesion kinase overexpression: correlation with lymph node metastasis and shorter survival in oral squamous cell carcinoma.Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment.Focal adhesion kinase is overexpressed in thymic epithelial tumors and may serve as an independent prognostic biomarker.Along with its favorable prognostic role, CLCA2 inhibits growth and metastasis of nasopharyngeal carcinoma cells via inhibition of FAK/ERK signaling.Prognostic significance of c-Met, β-catenin and FAK in patients with hepatocellular carcinoma following surgery.Effect of body composition on outcomes after hepatic resection for hepatocellular carcinoma.Association of the upregulated expression of focal adhesion kinase with poor prognosis and tumor dissemination in hypopharyngeal cancer.Reduced expression of focal adhesion kinase in intrahepatic cholangiocarcinoma is associated with poor tumor differentiation.In oral squamous cell carcinoma, high FAK expression is correlated with low P53 expression.
P2860
Q24797474-67FD9027-F56F-4842-88FC-F40AC1FB344AQ26765360-00BD6845-2FB0-4466-9D01-32207D47EA4FQ29547523-525DACEA-F251-4CF6-BCA5-A09BFD89E3FAQ30424344-38D4DB39-20BD-42E9-89CE-8AE55DE6E683Q33559593-737EFEFA-8164-4DE1-8561-3ACBC5AC5118Q33652164-D884966A-1A84-48B7-99B0-9719EDA27AE5Q33828369-233ACDEC-E0A3-4D55-9EDC-684DC2FA42C9Q33983579-AC457DE2-8ADB-4FBB-B8C9-09FC072B0B20Q34058734-BD5D239E-5646-43AB-AE0E-F0E1DBECFA96Q34162284-11741774-BC85-4E29-9F10-761C41AFE4ABQ34399693-97A04FCA-04F6-469C-A896-C3DCEEBB7CB5Q34791002-D244F356-1F04-48C1-AA4C-C00F693E3694Q35165208-BA49CFDE-E906-4E9D-953E-59EC2F7E9D0AQ36135842-32860F04-1B54-4223-A766-0745E1430BEBQ36244298-1C26ED67-9EE3-4A4F-85C2-37D76879086CQ36544501-CFB03A29-3269-4BE2-812B-0A758B9F4E02Q36725203-69A79856-F169-4750-B3C1-98B1C67DF511Q36905888-7817098B-FD6F-422D-862E-12B2ED60ADF7Q37644935-05BCC80B-F5D9-4D81-ABD3-852B2CE791E6Q38724729-6A7BFFBA-652C-4670-B671-326A478391E8Q38993878-0FAC2F8B-4A4D-454C-BFFD-2C2F383DB384Q40123406-0E058B36-A784-49BF-BA8D-A02A754D3D92Q40302237-E555C538-D20A-427F-B3C0-296B1B67344CQ41466023-F094AEC8-2612-40ED-A14A-DEF634D833FCQ42114895-872461FA-D264-48AC-881E-04D100378A67Q45351701-0CADCADA-9EC1-48FC-8FDF-2AB31267765CQ47699487-C0CE7325-1408-4C60-B081-083A4B5927EAQ49497914-E6814DD5-361F-4737-8254-DBC0ED8EA385Q49795695-41EE0E8D-7C11-456F-AEBD-337E446A47E2Q50284721-6AD927D4-4272-4BDD-8546-3FDC13ED5A0EQ53070653-0357D931-7731-4FB3-AD1F-5BD892B0BC17Q53126273-2E743CFA-E693-4ECE-A958-A23E6D54C5D3Q53535572-A3748941-E2A4-4AAD-AD81-5B7320898893Q54497749-AC9D6CDC-68C0-4460-BDDD-A526C6776C20
P2860
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
@en
type
label
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
@en
prefLabel
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
@en
P2093
P1476
Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma.
@en
P2093
Ken Shirabe
Mitsuo Shimada
Shin-ichi Aishima
Shinji Itoh
Shinji Tanaka
Takashi Maeda
P304
P356
10.1158/1078-0432.CCR-1046-03
P407
P577
2004-04-01T00:00:00Z